Issues associated with residual cell-substrate DNA in viral vaccines

Biologicals

Volumn 37, Issue 3, 2009, Pages 190-195

  Sheng Fowler, Li ^a   Lewis Jr , Andrew M ^a   Peden, Keith ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Infectious DNA; Oncogenic DNA; Risk evaluation

Indexed keywords

DNA; RESIDUAL CELL SUBSTRATE DNA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CANCER RISK; CARCINOGENESIS; DNA FRAGMENTATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RISK REDUCTION; SAFETY; VACCINATION; VIRUS INFECTIVITY;

ALGORITHMS; DNA; VIRAL VACCINES;

EID: 67349270964     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.02.015     Document Type: Article

References (81)

1. Hayflick L. A brief history of cell substrates used for the preparation of human biologicals. Dev Biol 106 (2001) 5-23
2. Plotkin S., Orenstein W., and Offit P. Vaccines. 5th ed. (2008), Saunders Elsevier
3. Robertson J.S., Nicolson C., Bootman J.S., Major D., Robertson E.W., and Wood J.M. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J Gen Virol 72 (1991) 2671-2677
4. Tree J.A., Richardson C., Fooks A.R., Clegg J.C., and Looby D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 19 (2001) 3444-3450
5. Medema J.K., Meijer J., Kersten A.J., and Horton R. Safety assessment of Madin Darby canine kidney cells as vaccine substrate. Dev Biol (Basel) 123 (2006) 243-250 [discussion 265-6]
6. Hilleman M.R. Cells, vaccines, and the pursuit of precedent. Natl Cancer Inst Monogr 29 (1968) 463-469
7. Hilleman M.R. Line cell saga - an argument in favor of production of biologics in cancer cells. Adv Exp Med Biol 118 (1979) 47-58
8. Lewis Jr. A.M., Krause P., and Peden K. A defined-risks approach to the regulatory assessment of the use of neoplastic cells as substrates for viral vaccine manufacture. Dev Biol 106 (2001) 513-535
9. Ishii K.J., Gursel I., Gursel M., and Klinman D.M. Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides. Curr Opin Mol Ther 6 (2004) 166-174
10. Rothenfusser S., Tuma E., Wagner M., Endres S., and Hartmann G. Recent advances in immunostimulatory CpG oligonucleotides. Curr Opin Mol Ther 5 (2003) 98-106
11. Bishop J.M., Baker B., Fujita D., McCombe P., Sheiness D., Smith K., et al. Genesis of a virus-transforming gene. Natl Cancer Inst Monogr 48 (1978) 219-223
12. Cooper G.M. Cellular transforming genes. Science 217 (1982) 801-806
13. Land H., Parada L.F., and Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304 (1983) 596-602
14. Santos E., Pulciani S., and Barbacid M. Characterization of a human transforming gene isolated from T24 bladder carcinoma cells. Fed Proc 43 (1984) 2280-2286
15. Bos T.J. Oncogenes and cell growth. Adv Exp Med Biol 321 (1992) 45-99
16. Thompson T.C., Southgate J., Kitchener G., and Land H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56 (1989) 917-930
17. Hayward W.S., Neel B.G., and Astrin S.M. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290 (1981) 475-480
18. Tsichlis P.N. Oncogenesis by Moloney murine leukemia virus. Anticancer Res 7 (1987) 171-180
19. Tsichlis P.N., and Lazo P.A. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr Top Microbiol Immunol 171 (1991) 95-171
20. Ben David Y., Prideaux V.R., Chow V., Benchimol S., and Bernstein A. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene 3 (1988) 179-185
21. Johnson P., and Benchimol S. Friend virus induced murine erythroleukaemia: the p53 locus. Cancer Surv 12 (1992) 137-151
22. Ledwith B.J., Manam S., Troilo P.J., Barnum A.B., Pauley C.J., Griffiths T.G., et al. Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology 43 (2000) 258-272
23. Ledwith B.J., Manam S., Troilo P.J., Barnum A.B., Pauley C.J., Griffiths T.G., et al. Plasmid DNA vaccines: assay for integration into host genomic DNA. Dev Biol (Basel) 104 (2000) 33-43
24. Temin H.M. Overview of biological effects of addition of DNA molecules to cells. J Med Virol 31 (1990) 13-17
25. Kurth R. Risk potential of the chromosomal insertion of foreign DNA. Ann N Y Acad Sci 772 (1995) 140-151
26. Coffin J.M. Molecular mechanisms of nucleic acid integration. J Med Virol 31 (1990) 43-49
27. Bullock P., Forrester W., and Botchan M. DNA sequence studies of simian virus 40 chromosomal excision and integration in rat cells. J Mol Biol 174 (1984) 55-84
28. Mooibroek H., Arnberg A.C., de Jong B., and Venema G. Effect of concentration on the subsequent fate of plasmid DNA in human fibroblasts. Mol Gen Genet 199 (1985) 82-88
29. Ruley H.E., and Fried M. Clustered illegitimate recombination events in mammalian cells involving very short sequence homologies. Nature 304 (1983) 181-184
30. Stary A., and Sarasin A. Molecular analysis of DNA junctions produced by illegitimate recombination in human cells. Nucleic Acids Res 20 (1992) 4269-4274
31. Yarom R., Lapidot A., Neer A., Baran N., and Manor H. 'Illegitimate' recombination events in polyoma-transformed rat cells. Gene 59 (1987) 87-98
32. Griffiths E. Major issues associated with the use of cell substrates for the production of vaccines. Dev Biol 106 (2001) 25-35
33. Krause P.R., and Lewis Jr. A.M. Safety of viral DNA in biological products. Biologicals 26 (1998) 317-320
34. Diderholm H., and Wesslen T. Infection of naturally insusceptible cells with DNA of polyoma and SV40 viruses. Acta Pathol Microbiol Scand 59 (1963) 271-272
35. Di Mayorca G.A., Eddy B.E., Stewart S.E., Hunter W.S., Friend C., and Bendich A. Isolation of infectious deoxyribonucleic acid from SE polyoma-infected tissue cultures. Proc Natl Acad Sci U S A 45 (1959) 1805-1808
36. Orth G., Atanasiu P., Boiron M., Rebiere J.P., and Paoletti C. Infectious and oncogenic effect of DNA extracted from cells infected with polyoma virus. Proc Soc Exp Biol Med 115 (1964) 1090-1095
37. Gerber P. An infectious deoxyribonucleic acid derived from vacuolating virus (SV40). Virology 16 (1962) 96-97
38. Watts S.L., Ostrow R.S., Phelps W.C., Prince J.T., and Faras A.J. Free cottontail rabbit papillomavirus DNA persists in warts and carcinomas of infected rabbits and in cells in culture transformed with virus or viral DNA. Virology 125 (1983) 127-138
39. Brandsma J.L., Yang Z.H., Barthold S.W., and Johnson E.A. Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A 88 (1991) 4816-4820
40. Brandsma J.L., and Xiao W. Infectious virus replication in papillomas induced by molecularly cloned cottontail rabbit papillomavirus DNA. J Virol 67 (1993) 567-571
41. McBride A.A., Dlugosz A., and Baker C.C. Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique. Proc Natl Acad Sci U S A 97 (2000) 5534-5539
42. Nasseri M., Meyers C., and Wettstein F.O. Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation. Virology 170 (1989) 321-325
43. Burnett J.P., and Harrington J.A. Infectivity associated with simian adenovirus type SA7 DNA. Nature 220 (1968) 1245
44. Burnett J.P., and Harrington J.A. Simian adenovirus SA7 DNA: chemical, physical, and biological studies. Proc Natl Acad Sci U S A 60 (1968) 1023-1029
45. Sutjipto S., and Simmons D.G. Turkey respiratory tract adenoviruses: in vitro infectivity of purified DNA. Am J Vet Res 42 (1981) 495-497
46. Graham F.L. Covalently closed circles of human adenovirus DNA are infectious. Embo J 3 (1984) 2917-2922
47. Fleckenstein B., Bornkamm G.W., and Ludwig H. Repetitive sequences in complete and defective genomes of Herpesvirus saimiri. J Virol 15 (1975) 398-406
48. Allen G.P., and Randall C.C. Biological properties of equine herpesvirus type 1 DNA: transfectivity and transforming capacity. Infect Immun 22 (1978) 34-40
49. Miller G., Grogan E., Heston L., Robinson J., and Smith D. Epstein-Barr viral DNA: infectivity for human placental cells. Science 212 (1981) 452-455
50. Cameron I.R., Wilkie N.M., and Macnab J.C. The infectivity of herpes simplex virus DNA in rat embryo cells is enhanced synergistically by DMSO and glucose. J Virol Methods 6 (1983) 183-191
51. Tognon M., Cattozzo E.M., Bianchi S., and Romanelli M.G. Enhancement of HSV-DNA infectivity, in VERO and RS cells, by a modified calcium-phosphate transfection technique. Virus Genes 12 (1996) 193-197
52. Kaaden O.R. Transfection studies in vitro and in vivo with isolated Marek's disease virus DNA. IARC Sci Publ 24 (1978) 627-633
53. Casal J.I., Diaz-Aroca E., Ranz A.I., and Manclus J.J. Construction of an infectious genomic clone of porcine parvovirus: effect of the 5′-end on DNA replication. Virology 177 (1990) 764-767
54. Laughlin C.A., Tratschin J.D., Coon H., and Carter B.J. Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23 (1983) 65-73
55. Merchlinsky M.J., Tattersall P.J., Leary J.J., Cotmore S.F., Gardiner E.M., and Ward D.C. Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice. J Virol 47 (1983) 227-232
56. Senapathy P., and Carter B.J. Molecular cloning of adeno-associated virus variant genomes and generation of infectious virus by recombination in mammalian cells. J Biol Chem 259 (1984) 4661-4666
57. Zhi N., Zadori Z., Brown K.E., and Tijssen P. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318 (2004) 142-152
58. Samulski R.J., Berns K.I., Tan M., and Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A 79 (1982) 2077-2081
59. Fisher A.G., Collalti E., Ratner L., Gallo R.C., and Wong-Staal F. A molecular clone of HTLV-III with biological activity. Nature 316 (1985) 262-265
60. Adachi A., Gendelman H.E., Koenig S., Folks T., Wiley R., Rabson A., et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59 (1986) 284-291
61. Barker C.S., Pickel J., Tainsky M., and Hunter E. Molecular cloning of the Mason-Pfizer monkey virus genome: biological characterization of genome length clones and molecular comparisons to other retroviruses. Virology 153 (1986) 201-214
62. Itohara S., and Sekikawa K. Molecular cloning of infectious proviral genomes of bovine leukemia virus. Virology 159 (1987) 158-160
63. Olmsted R.A., Barnes A.K., Yamamoto J.K., Hirsch V.M., Purcell R.H., and Johnson P.R. Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci U S A 86 (1989) 2448-2452
64. Regier D.A., and Desrosiers R.C. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 6 (1990) 1221-1231
65. Inabe K., Ikuta K., and Aida Y. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus. Virology 245 (1998) 53-64
66. Israel M.A., Chan H.W., Hourihan S.L., Rowe W.P., and Martin M.A. Biological activity of polyoma viral DNA in mice and hamsters. J Virol 29 (1979) 990-996
67. Brandsma J.L., Yang Z.H., DiMaio D., Barthold S.W., Johnson E., and Xiao W. The putative E5 open reading frame of cottontail rabbit papillomavirus is dispensable for papilloma formation in domestic rabbits. J Virol 66 (1992) 6204-6207
68. Kreider J.W., Cladel N.M., Patrick S.D., Welsh P.A., DiAngelo S.L., Bower J.M., et al. High efficiency induction of papillomas in vivo using recombinant cottontail rabbit papillomavirus DNA. J Virol Methods 55 (1995) 233-244
69. Letvin N.L., Lord C.I., King N.W., Wyand M.S., Myrick K.V., and Haseltine W.A. Risks of handling HIV. Nature 349 (1991) 573
70. Willems L., Portetelle D., Kerkhofs P., Chen G., Burny A., Mammerickx M., et al. In vivo transfection of bovine leukemia provirus into sheep. Virology 189 (1992) 775-777
71. Willems L., Thienpont E., Kerkhofs P., Burry A., Mammerickx M., and Kettmann R. In vivo infection of sheep by bovine leukemia virus mutants. J Virol 67 (1993) 4078-4085
72. Liska V., Khimani A.H., Hofmann-Lehmann R., Fink A.N., Vlasak J., and Ruprecht R.M. Viremia and AIDS in rhesus macaques after intramuscular inoculation of plasmid DNA encoding full-length SIVmac239. AIDS Res Hum Retroviruses 15 (1999) 445-450
73. Kent S.J., Dale C.J., Preiss S., and Purcell D.F. Evidence of recombination between 3′ and 5′ LTRs in macaques inoculated with SIV DNA. AIDS Res Hum Retroviruses 18 (2002) 227-230
74. Kent S.J., Dale C.J., Preiss S., Mills J., Campagna D., and Purcell D.F. Vaccination with attenuated simian immunodeficiency virus by DNA inoculation. J Virol 75 (2001) 11930-11934
75. Purcell D.F., Cameron P.U., Mills J., and Kent S. Infectivity of wild-type and deleted proviral SIV DNA. Dev Biol 106 (2001) 395-406
76. Petricciani J.C., and Horaud F.N. DNA, dragons and sanity. Biologicals 23 (1995) 233-238
77. Petricciani J.C., and Regan P.J. Risk of neoplastic transformation from cellular DNA: calculations using the oncogene model. Dev Biol Scand 68 (1987) 43-49
78. Petricciani J., and Loewer J. An overview of cell DNA issues. Dev Biol 106 (2001) 275-282
79. Sheng L., Cai F., Zhu Y., Pal A., Athanasiou M., Orrison B., et al. Oncogenicity of DNA in vivo: tumor induction with expression plasmids for activated H-ras and c-myc. Biologicals 36 (2008) 184-197
80. Burns P.A., Jack A., Neilson F., Haddow S., and Balmain A. Transformation of mouse skin endothelial cells in vivo by direct application of plasmid DNA encoding the human T24 H-ras oncogene. Oncogene 6 (1991) 1973-1978
81. Peden K., Sheng L., Pal A., and Lewis A. Biological activity of residual cell-substrate DNA. Dev Biol (Basel) 123 (2006) 45-53 [discussion 55-73]